|
【结 构 式】 
|
【分子编号】10477 【品名】3-Bromobenzaldehyde; m-Bromobenzaldehyde 【CA登记号】3132-99-8 |
【 分 子 式 】C7H5BrO 【 分 子 量 】185.0201 【元素组成】C 45.44% H 2.72% Br 43.19% O 8.65% |
合成路线1
该中间体在本合成路线中的序号：(VI)The synthesis of tritium-labeled taxol [3''-3H]-taxol has been described: The reaction of baccatin III (I) with chlorotriethylsilane in pyridine gives the protected compound (II), which is condensed with cis-1-benzoyl-4-(3-bromophenyl)-3-(triethylsilyloxy)azetidin-2-one (III) by means of butyllithium in THF, yielding 3''-bromo-2',7-bis-O-(triethylsilyl)taxol (IV). The deprotection of (IV) with pyridine and 48% HF in THF affords 3''-bromotaxol (V), which is finally debrominated with tritium by means of Pd/C and triethylamine in THF. The starting azetidinone (III) is obtained as follows: The condensation of 3-bromobenzaldehyde (VI) with 4-methoxyaniline (VII) in refluxing benzene gives the enamine (VIII), which is cyclized with acetoxyacetyl chloride (IX) by means of triethylamine in dichloromethane, yielding cis-3-acetoxy-4-(3-bromophenyl)-1-(4-methoxyphenyl)azetidin-2-one (X). The reaction of (X) with ceric ammonium nitrate (CAN) in acetonitrile affords cis-3-acetoxy-4-(3-bromophenyl)azetidin-2-one (XI), which is deacetylated with KOH in THF-water giving cis-4-(3-bromophenyl)-3-hydroxyazetidin-2-one (XII). The silylation of (XII) with chlorotriethylsilane in pyridine yields cis-4-(3-bromophenyl)-3-(triethylsilyloxy)azetidin-2-one (XIII), which is finally benzoylated with benzoyl chloride (XIV) and butyllithium in THF to afford the desired azetidinone (III).
| 【1】 Taylor, G.F.; Thornton, S.S.; Tallent, C.R.; Kepler, J.A.; Synthesis of [3''-3H]taxol and [13-3H]taxol. J Label Compd Radiopharm 1993, 33, 6, 501. |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| (I) | 10447 | (1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetoxy)-1,9,15-trihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl benzoate | C31H38O11 | 详情 | 详情 | |
| (II) | 10473 | (1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetoxy)-1,15-dihydroxy-10,14,17,17-tetramethyl-11-oxo-9-[(triethylsilyl)oxy]-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl benzoate | C37H52O11Si | 详情 | 详情 | |
| (III) | 10474 | (3R,4S)-1-Benzoyl-4-(3-bromophenyl)-3-[(triethylsilyl)oxy]-2-azetidinone | C22H26BrNO3Si | 详情 | 详情 | |
| (IV) | 10475 | (1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetoxy)-15-([(2R,3S)-3-(benzoylamino)-3-(3-bromophenyl)-2-[(triethylsilyl)oxy]propanoyl]oxy)-1-hydroxy-10,14,17,17-tetramethyl-11-oxo-9-[(triethylsilyl)oxy]-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl benzoate | C59H78BrNO14Si2 | 详情 | 详情 | |
| (V) | 10476 | (1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetoxy)-15-[[(2R,3S)-3-(benzoylamino)-3-(3-bromophenyl)-2-hydroxypropanoyl]oxy]-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl benzoate | C47H50BrNO14 | 详情 | 详情 | |
| (VI) | 10477 | 3-Bromobenzaldehyde; m-Bromobenzaldehyde | 3132-99-8 | C7H5BrO | 详情 | 详情 |
| (VII) | 10478 | p-Anisidine; 4-Methoxyaniline; 4-Methoxyphenylamine | 104-94-9 | C7H9NO | 详情 | 详情 |
| (VIII) | 10479 | N-[(Z)-(3-Bromophenyl)methylidene]-N-(4-methoxyphenyl)amine; N-[(Z)-(3-Bromophenyl)methylidene]-4-methoxyaniline | C14H12BrNO | 详情 | 详情 | |
| (IX) | 10456 | Acetoxiacetil chloride; 2-chloro-2-oxoethyl acetate | 13831-31-7 | C4H5ClO3 | 详情 | 详情 |
| (X) | 10481 | (2S,3R)-2-(3-bromophenyl)-1-(4-methoxyphenyl)-4-oxoazetanyl acetate | C18H16BrNO4 | 详情 | 详情 | |
| (XI) | 10482 | (2S,3R)-2-(3-bromophenyl)-4-oxoazetanyl acetate | C11H10BrNO3 | 详情 | 详情 | |
| (XII) | 10483 | (3R,4S)-4-(3-Bromophenyl)-3-hydroxy-2-azetanone | C9H8BrNO2 | 详情 | 详情 | |
| (XIII) | 10484 | (3R,4S)-4-(3-Bromophenyl)-3-[(triethylsilyl)oxy]-2-azetanone | C15H22BrNO2Si | 详情 | 详情 | |
| (XIV) | 10463 | Benzoyl chloride | 98-88-4 | C7H5ClO | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号：(XXIII)In an alternative procedure, the silylether of 3-bromophenol (XIX) was converted to the organolithium compound (XXII) and then coupled to 3-bromobenzaldehyde (XXIII) in THF at -78 C. The resulting benzhydrol (XXIV) was treated with SOCl2 to give chloride (XXV), which was subsequently condensed with piperazine (V) in refluxing acetonitrile. The diastereomeric mixture of benzhydryl piperazines (XXVI) was desilylated with tetraethylammonium fluoride, and the major isomer (XXVII) was isolated by recrystallization from acetonitrile. The bromo substituent of (XXVII) was then substituted for a cyano group upon treatment with CuCN in N-methylpyrrolidinone at 170 C. Basic hydrolysis of nitrile (XXVIII) gave acid (XXIX), which was protected as the tert-butyldimethylsilyl ether and further converted to acid chloride (XXX) by reaction with oxalyl chloride and a catalytic amount of DMF. Finally, acid chloride (XXX) was condensed with N-methyl-3-fluoroaniline (XIV), and the silyl protecting group was removed by treatment with tetraethylammonium fluoride in acetonitrile.
| 【1】 Chang, K.-J.; Bishop, M.J.; Bubacz, D.G.; McNutt, R.W. Jr. (Glaxo Wellcome plc); Piperazine cpds. used in therapy. EP 0711289; JP 1997501156; WO 9504051 . |
| 【2】 Chang, K.; Boswell, G.E.; Bubacz, D.G.; Collins, M.A.; Davis, A.O.; McNutt, R.W. (Delta Pharmaceuticals, Inc.); Opioid diarylmethylpiperazines and piperidines. JP 1995503247; US 5658908; US 5681830; WO 9315062 . |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| (V) | 20690 | (2R,5S)-1-allyl-2,5-dimethylpiperazine | C9H18N2 | 详情 | 详情 | |
| (XIV) | 20700 | 3-fluoro-N-methylaniline; N-(3-fluorophenyl)-N-methylamine | C7H8FN | 详情 | 详情 | |
| (XIX) | 20705 | (3-bromophenoxy)(tert-butyl)dimethylsilane; 3-bromophenyl tert-butyl(dimethyl)silyl ether | 65423-56-5 | C12H19BrOSi | 详情 | 详情 |
| (XXII) | 20708 | (3-[[tert-butyl(dimethyl)silyl]oxy]phenyl)lithium | C12H19LiOSi | 详情 | 详情 | |
| (XXIII) | 10477 | 3-Bromobenzaldehyde; m-Bromobenzaldehyde | 3132-99-8 | C7H5BrO | 详情 | 详情 |
| (XXIV) | 20710 | (3-bromophenyl)(3-[[tert-butyl(dimethyl)silyl]oxy]phenyl)methanol | C19H25BrO2Si | 详情 | 详情 | |
| (XXV) | 20711 | 3-[(3-bromophenyl)(chloro)methyl]phenyl tert-butyl(dimethyl)silyl ether; [3-[(3-bromophenyl)(chloro)methyl]phenoxy](tert-butyl)dimethylsilane | C19H24BrClOSi | 详情 | 详情 | |
| (XXVI) | 20712 | (2R,5S)-1-allyl-4-[(3-bromophenyl)(3-[[tert-butyl(dimethyl)silyl]oxy]phenyl)methyl]-2,5-dimethylpiperazine; 3-[[(2S,5R)-4-allyl-2,5-dimethylpiperazinyl](3-bromophenyl)methyl]phenyl tert-butyl(dimethyl)silyl ether | C28H41BrN2OSi | 详情 | 详情 | |
| (XXVII) | 20713 | 3-[(S)-[(2S,5R)-4-allyl-2,5-dimethylpiperazinyl](3-bromophenyl)methyl]phenol | C22H27BrN2O | 详情 | 详情 | |
| (XXVIII) | 20714 | 3-[(R)-[(2S,5R)-4-allyl-2,5-dimethylpiperazinyl](3-hydroxyphenyl)methyl]benzonitrile | C23H27N3O | 详情 | 详情 | |
| (XXIX) | 20715 | 3-[(R)-[(2S,5R)-4-allyl-2,5-dimethylpiperazinyl](3-hydroxyphenyl)methyl]benzoic acid | C23H28N2O3 | 详情 | 详情 | |
| (XXX) | 20716 | 3-[(R)-[(2S,5R)-4-allyl-2,5-dimethylpiperazinyl](3-[[tert-butyl(dimethyl)silyl]oxy]phenyl)methyl]benzoyl chloride | C29H41ClN2O2Si | 详情 | 详情 |
合成路线3
该中间体在本合成路线中的序号：(I)The condensation between 3-bromobenzaldehyde (I), 1-(6-morpholinyl-3-pyridinyl)ethanone (II) and malononitrile in the presence of ammonium acetate in refluxing benzene produced the bipyridyl derivative (III). Then treatment of (III) with refluxing formamide gave the title pyridopyrimidine.
| 【1】 Lee, C.-H.; et al.; Discovery of 4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin-3-yl) pyrido[2,3-d]pyrimidine, an orally active, non-nucleoside adenosine kinase inhibitor. J Med Chem 2001, 44, 13, 2133. |
| 【2】 Cowart, M.D.; Lee, C.-H.; Grillot, A.L.; Bhagwat, S.S.; McKie, J. (Abbott Laboratories Inc.); 5,7-Disubstd.-4-aminopyrido[2,3-d]pyrimidine cpds. and their use as adenosine kinase inhibitors. EP 0989986; WO 9846605 . |
| 【3】 Stewart, A.O.; Perner, R.J.; McKie, J.A.; Zheng, G.Z.; Grillot, A.L.; Cowart, M.D.; Bhagwat, S.S.; Lee, C.-H. (Abbott Laboratories Inc.); 5,7-Disubstd.-4-aminopyrido[2,3-d]pyrimidine cpds.. WO 0023444 . |
合成路线4
该中间体在本合成路线中的序号：(VII)6-Chloronicotinic acid (I) was converted to the corresponding acid chloride (II) by treatment with oxalyl chloride. Condensation of acid chloride (II) with diethyl malonate in the presence of MgCl2 and Et3N produced the keto diester (III), which was further decarbethoxylated to ketone (IV) upon heating in moist DMSO. Displacement of the chloride group of (III) with 4-piperidone ethylene ketal (V) furnished the piperidinyl pyridine (VI). Knoevenagel condensation of malononitrile with 3-bromobenzaldehyde (VII) using glycine as the catalyst produced the benzylidene malononitrile (VIII). The dipyridyl derivative (IX) was obtained by condensation of ketone (VI) with dinitrile (VIII) in the presence of ammonium acetate. Cyclization of amino nitrile (IX) in hot formamide gave rise to the pyridopyrimidine system (X). Ketone (XI) was then obtained by acid hydrolysis of the ethylene ketal function of (X). Finally, condensation of ketone (XI) with 4-tetrahydropyranyloxyamine (XII) yielded the title oxime.
| 【1】 Zheng, G.Z.; et al.; Pyridopyrimidine analogues as novel adenosine kinase inhibitors. Bioorg Med Chem Lett 2001, 11, 16, 2071. |
| 【2】 Stewart, A.O.; Perner, R.J.; McKie, J.A.; Zheng, G.Z.; Grillot, A.L.; Cowart, M.D.; Bhagwat, S.S.; Lee, C.-H. (Abbott Laboratories Inc.); 5,7-Disubstd.-4-aminopyrido[2,3-d]pyrimidine cpds.. WO 0023444 . |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| (I) | 12996 | 6-Chloronicotinic acid | 5326-23-8 | C6H4ClNO2 | 详情 | 详情 |
| (II) | 30256 | 6-chloronicotinoyl chloride | 58757-38-3 | C6H3Cl2NO | 详情 | 详情 |
| (III) | 49834 | dimethyl 2-[(6-chloro-3-pyridinyl)carbonyl]malonate | C11H10ClNO5 | 详情 | 详情 | |
| (IV) | 26555 | 1-(6-chloro-3-pyridinyl)-1-ethanone | C7H6ClNO | 详情 | 详情 | |
| (V) | 11338 | 1,4-Dioxa-8-azaspiro[4.5]decane; 4-Piperidone ethylene ketal | 177-11-7 | C7H13NO2 | 详情 | 详情 |
| (VI) | 49835 | 1-[6-(1,4-dioxa-8-azaspiro[4.5]dec-8-yl)-3-pyridinyl]-1-ethanone | C14H18N2O3 | 详情 | 详情 | |
| (VII) | 10477 | 3-Bromobenzaldehyde; m-Bromobenzaldehyde | 3132-99-8 | C7H5BrO | 详情 | 详情 |
| (VIII) | 49836 | 2-(3-bromobenzylidene)malononitrile | C10H5BrN2 | 详情 | 详情 | |
| (IX) | 49837 | C24H22BrN5O2 | 详情 | 详情 | ||
| (X) | 49838 | 5-(3-bromophenyl)-7-[6-(1,4-dioxa-8-azaspiro[4.5]dec-8-yl)-3-pyridinyl]pyrido[2,3-d]pyrimidin-4-amine; 5-(3-bromophenyl)-7-[6-(1,4-dioxa-8-azaspiro[4.5]dec-8-yl)-3-pyridinyl]pyrido[2,3-d]pyrimidin-4-ylamine | C25H23BrN6O2 | 详情 | 详情 | |
| (XI) | 49839 | 1-[5-[4-amino-5-(3-bromophenyl)pyrido[2,3-d]pyrimidin-7-yl]-2-pyridinyl]-4-piperidinone | C23H19BrN6O | 详情 | 详情 | |
| (XII) | 49840 | O-tetrahydro-2H-pyran-4-ylhydroxylamine; 4-(aminooxy)tetrahydro-2H-pyran | C5H11NO2 | 详情 | 详情 |